Doptelet approved for liver disease patients slated for a medical procedure
(HealthDay)—Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.
May 21, 2018